A practical guide for startups, founders, and manufacturers navigating EU MDR and UK market access — without overpaying or overcomplicating the process.
Choose based on fit with your stage and device type, not firm size or brand. You need hands-on EU MDR experience, demonstrated ability to build documentation from scratch, and understanding of your specific device type — especially SaMD or AI-enabled devices. Early engagement before writing documentation is almost always cheaper than late-stage correction.
If you're developing a medical device, you've probably already realised that regulatory requirements are complex, advice online is inconsistent, and most consultants sound the same.
The result is usually one of three outcomes: you delay decisions because you don't know where to start, you hire the wrong type of support and have to start over, or you overpay for services you don't need yet.
This guide helps you avoid all three.
Not every company needs full-service regulatory consulting from day one. But there are clear signals that it's time to get structured help.
If even one of these applies, you don't need more information. You need structured regulatory direction.
What they offer
What to be aware of
What they offer
Limitations
What this looks like
EU MDR is fundamentally different from its predecessor — and significantly more demanding. Experience under the old MDD framework does not automatically transfer. Ask specifically about MDR experience and the types of devices they've worked with under the new regulation.
Early-stage companies have different needs than established manufacturers. You need someone who can prioritise what matters at your stage, make practical decisions without over-engineering, and work within your timeline and budget constraints.
Most startups don't have clinical evaluation reports, risk management files, or technical documentation in place. Your regulatory partner must be able to build these with you — not just review what already exists.
This is especially important for Software as a Medical Device (SaMD), digital health solutions, and devices with AI or machine learning components. SaMD classification and evidence requirements are distinct from hardware devices — make sure your consultant knows the difference.
Engaging regulatory support after development is well underway often leads to rework, costly design changes, and delayed market access.
A large firm is not always the right choice. What matters is whether their experience and approach match your product, stage, and goals.
Full-service engagement at the idea or prototype stage often means paying for documentation you're not ready for. Staged support is more efficient.
Regulatory compliance is a strategic process, not a box-ticking exercise. Early decisions — especially around classification — define the entire pathway.
The best time to engage regulatory support is before you start building documentation, before you finalise your intended use statement, and before you commit to a regulatory pathway.
Waiting too long often means incorrect classification, wasted development effort, and costly rework before submission. Early regulatory input is almost always cheaper than late correction.
Not size. Not brand. Fit with your stage, your product, and your goals. The most important outcome of good regulatory support is that you can move forward with clarity — not just with more information.
Book a free discovery call. We'll help you define your regulatory starting point, understand your pathway under EU MDR or UKCA, and avoid the most common early mistakes.
Book a free discovery callYou need structured regulatory help if you are building a device with no documentation, unsure of classification, preparing for CE or UKCA marking, entering the UK market as a non-UK manufacturer, or verifying supplier documentation as a distributor. The earlier you engage, the lower the cost of correction.
Not necessarily. Large firms offer broad resources but can be expensive and over-engineered for early-stage needs. Specialist regulatory support matched to your product stage is usually more cost-effective and faster to engage for startups and SMEs.
Look for hands-on EU MDR experience (not just legacy MDD), demonstrated ability to build documentation from scratch, experience with your device type — especially SaMD or AI-enabled devices — and a clear, proportionate scope that matches your stage.
Before you start writing documentation, before finalising intended use, and before committing to a regulatory pathway. Early regulatory input is almost always cheaper than late-stage correction. The right time is as early as possible in the product development process.